NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - DESANTIS CARL

Filed: 2026-04-17 AccNo: 0001102948-26-000002 Size: 7 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/17 15:58 UTC
首次发现04/17 16:01 UTC
热度106.3
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 509 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001102948-26-000002

Filing Date: 2026-04-17

Accepted: 2026-04-17 11:58:42

Documents: 1

Period of Report: 2026-04-15

INTEGRATED BIOPHARMA INC ( Issuer ) CIK : 0001016504 (see all company filings) EIN. : 222407475 | State of Incorp.: DE | Fiscal Year End: 0630 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | PRIMARY DOCUMENT | primary_doc.html | 4

1 | PRIMARY DOCUMENT | primary_doc.xml | 4